menu search

ANIK / Anika Therapeutics, Inc. (ANIK) Q3 2023 Earnings Call Transcript

Anika Therapeutics, Inc. (ANIK) Q3 2023 Earnings Call Transcript
Anika Therapeutics, Inc. (NASDAQ:ANIK ) Q3 2023 Earnings Conference Call November 2, 2023 5:30 PM ET Company Participants Mark Namaroff - Vice President Investor Relations, ESG & Corporate Communications Cheryl Blanchard - President & Chief Executive Officer Mike Levitz - Executive Vice President, Chief Financial Officer & Treasurer Conference Call Participants Mike Petusky - Barrington Research George Sellers - Stephens Inc Jim Sidoti - Sidoti & Company Operator Good evening, ladies and gentlemen, and welcome to Anika's Third Quarter 2023 Earnings Conference Call. All participants' will be in a listen-only mode. Read More
Posted: Nov 3 2023, 16:34
Author Name: Seeking Alpha
Views: 062317

ANIK News  

Anika Therapeutics, Inc. (ANIK) Q3 2023 Earnings Call Transcript

By Seeking Alpha
November 3, 2023

Anika Therapeutics, Inc. (ANIK) Q3 2023 Earnings Call Transcript

Anika Therapeutics, Inc. (NASDAQ:ANIK ) Q3 2023 Earnings Conference Call November 2, 2023 5:30 PM ET Company Participants Mark Namaroff - Vice Preside more_horizontal

Down -20.42% in 4 Weeks, Here's Why You Should You Buy the Dip in Anika (ANIK)

By Zacks Investment Research
September 1, 2023

Down -20.42% in 4 Weeks, Here's Why You Should You Buy the Dip in Anika (ANIK)

The heavy selling pressure might have exhausted for Anika (ANIK) as it is technically in oversold territory now. In addition to this technical measure more_horizontal

All You Need to Know About Anika (ANIK) Rating Upgrade to Buy

By Zacks Investment Research
August 31, 2023

All You Need to Know About Anika (ANIK) Rating Upgrade to Buy

Anika (ANIK) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stoc more_horizontal

Anika (ANIK) Loses -19.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

By Zacks Investment Research
August 31, 2023

Anika (ANIK) Loses -19.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Anika (ANIK) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong ag more_horizontal

Anika Therapeutics (ANIK) Reports Q2 Loss, Tops Revenue Estimates

By Zacks Investment Research
August 8, 2023

Anika Therapeutics (ANIK) Reports Q2 Loss, Tops Revenue Estimates

Anika Therapeutics (ANIK) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.34. This compares to l more_horizontal

Anika Therapeutics Inc. (ANIK) Q1 2023 Earnings Call Transcript

By Seeking Alpha
May 13, 2023

Anika Therapeutics Inc. (ANIK) Q1 2023 Earnings Call Transcript

Anika Therapeutics Inc. (NASDAQ:ANIK ) Q1 2023 Results Conference Call May 9, 2023 5:00 PM ET Company Participants Mark Namaroff - Executive Director more_horizontal

Anika Therapeutics (ANIK) Reports Q1 Loss, Tops Revenue Estimates

By Zacks Investment Research
May 9, 2023

Anika Therapeutics (ANIK) Reports Q1 Loss, Tops Revenue Estimates

Anika Therapeutics (ANIK) came out with a quarterly loss of $0.71 per share versus the Zacks Consensus Estimate of a loss of $0.36. This compares to l more_horizontal

Anika Therapeutics (ANIK) Reports Q4 Loss, Tops Revenue Estimates

By Zacks Investment Research
March 6, 2023

Anika Therapeutics (ANIK) Reports Q4 Loss, Tops Revenue Estimates

Anika (ANIK) delivered earnings and revenue surprises of -54.55% and 3.41%, respectively, for the quarter ended December 2022. Do the numbers hold clu more_horizontal


Search within

Pages Search Results: